Jianliang Shen

57PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiomaterialsNanomaterialsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Jul 25, 2026
A Multiple Enzyme-Mimetic Platinum-Ruthenium Nanohybrid Prodrug Potentiates Chemo-/Chemodynamic-/Immuno-Therapy of Hypoxic Tumors.

|Jun 20, 2026
A Self-Immunoregulatory Nanosensitizer for Sonodynamic Cancer Therapy.

|Jun 02, 2026
A Self-Cascading Immunomodulatory Hydrogel for Remodeling Infected Diabetic Wounds.

|May 20, 2026
Synergistic Chemoimmunotherapy of Hepatocellular Carcinoma via ROS-Responsive Carrier-Free Prodrug Nanoparticles.

|Apr 02, 2026
Copper Depletion Nanoparticles Potentiate Cancer Immunotherapy by Avoiding Innate and Adaptive Immune Resistance.

Zaigang Zhou, Ke Li, Xuelan Li

|Mar 12, 2026
Multifunctional ruthenium-based complexes for chronic wound therapy: from ligand engineering to intelligent microenvironment remodeling.

Yulong Lan, Jianliang Shen, Lifeng Tan

Pageof 10

Frequent Collaborators

9 joint publications

Xiaoliang Qi

3 joint publications

Ji-Ting Hou

2 joint publications

Chaofeng Mu

2 joint publications

Yan Xie